CDCl3): d = 7.343–7.338 (d, J = 2 Hz, 1H, CHAr);
7.327–7.316 (t, J = 4.4 Hz, 1H, CHAr); 7.286–7.280 (t, J =
2.4 Hz, 1H, CHAr); 7.267–7.262 (d, J = 2 Hz, 1H, CHAr);
4.835–4.802 (dd, J = 9.2, 4 Hz, 1H, CH*(OH)); 2.954–2.896
(td, J = 8.8, 4 Hz, 1H, CHali); 2.814–2.738 (qd, J = 9.6, 3.2
Hz, 1H, CHali); 2.628–2.617 (d, J = 4.4 Hz, 1H, CHali);
2.425–2.353 (qd, J = 8, 3.2 Hz, 1H, CHali); 1.892–1.825
(m, 1H, CHali); 1.606–1.571 (m, 1H, CHali); 1.531–1.473 (m,
1H, CHali); 1.392–1.160 (m, 15H, CHali). 13C NMR (100 MHz,
CDCl3): d = 214.7, 140.6, 133.7, 128.7, 128.0, 74.4, 58.9, 39.7,
27.3, 26.4, 25.9, 24.2, 23.8, 23.7, 22.6, 22.4, 21.5. FTIR (KBr)
n = 3411.89, 3055.80, 2932.90, 2857.00, 1687.46, 1596.64,
1375.43, 1291.41, 1139.02, 822.98, 731.68, 602.81. HRMS
(EI) m/z: Calc. for C19H27ClO2; 322.1699 [M]+; Found
322.1700.
(d, J = 8 Hz, 1H, CHAr); 7.888–7.865 (d, J = 8.8 Hz, 1H,
CHAr); 7.807–7.787 (d, J = 8 Hz, 1H, CHAr); 7.562–7.431
(m, 4H, CHAr); 5.566–5.536 (dd, J = 8, 4 Hz, 1H, CH*(OH));
3.412–3.367 (td, 4.5, 3.2 Hz, 1H, CH*–CHOH); 2.910 (s, 1H,
OH); 2.714–2.640 (qd, J = 8, 3.2 Hz, 1H, CHali); 2.433–2.360
(qd, J = 8.4, 3.2 Hz, 1H, CHali); 1.784–1.606 (m, 3H, CH2ali);
1.299–1.075 (m, 15H, CHali ). 13C NMR (100 MHz, CDCl3):
d = 215.4, 137.7, 134.0, 130.8, 129.0, 128.6, 126.2, 125.6,
125.3, 124.6, 123.4, 73.0, 57.7, 40.4, 28.2, 26.4, 25.8, 24.3, 24.1,
23.4, 22.4, 21.6. FTIR (KBr) n = 3417.40, 3065.26, 2920.95,
2846.49, 1696.30, 1517.53, 1453.65, 1365.83, 1324.23, 1140.69,
1036.67, 830.66, 736.13, HRMS (EI) m/z: Calc. for C23H30O2;
338.2245 [M]+; Found 338.2246.
(E)-1-(2-Chlorobenylidene) cyclododecanone (5a)
The white crude solid was subjected to column chromato-
graphy on silica gel (n-hexane/EtOAc, 7 : 3 ) to afford the
monobenzylidene product 5a (2.42 g, 79% E/Z = 96/4), Rf 0.4
(n-hexane/EtOAc, 4 : 1); white crystalline solid; Mp: 93–95 1C;
1H NMR (400 MHz, CDCl3): d = 7.464 (s, 1H, CHvinylic);
7.445–7.421 (td, 4.4, 1.2 Hz, 1H, CHAr); 7.288–7.256 (m, 3H,
CHAr); 2.873–2.842 (m, 2H, CH2ali); 2.549–2.519 (t, 12 Hz,
2H, CH2ali); 1.866 (bs, 2H, CH2ali); 1.318 (s, 11H, CH2ali);
1.245 (s, 1H, CHali); 1.136–1.110 (t, J = 10.4 Hz, 2H, CH2ali).
13C NMR (100 MHz, CDCl3): d = 205.0, 143.2, 136.0, 134.7,
133.8, 130.3, 129.4, 129.2, 126.4, 38.8, 26.5, 26.4, 25.4, 24.4,
24.2, 24.1, 23.9, 23.1, 22.5. FTIR (KBr) n = 3515.35 [(broad
peak) absence of OH peak], 3066.80, 2939.97, 2855.73,
1661.73, 1465.48, 1361.77, 1239.93, 1157.74, 939.21, 870.34,
767.87, 692.52. HRMS (EI) m/z: Calc. for C19H25ClO;
304.1593 [M]+; Found 304.1594.
2-[(4-Bromophenyl) (hydroxy) methyl] cyclododecanone (4i)
The crude residue was then purified by column chromatogra-
phy on silica gel (n-hexane/EtOAc, 7 : 2) to afford the anti-
aldol product 4i (3.165 g, 89%, dr = 100 : 0) as a white
crystalline solid; Mp: 154–156 1C; 1H NMR (400 MHz,
CDCl3): d = 7.49–7.46 (m, 2H, CHAr); 7.22–7.20 (d, J =
8 Hz, 2H, CHAr); 4.80–4.77 (dd, J = 8, 4 Hz, 1H, CH*(OH));
2.93–2.89 (td, J = 8, 4 Hz, 1H, CHali); 2.80–2.74 (qd, J = 8,
4 Hz, 2H, CH2ali); 2.43–2.36 (qd, J = 12, 4 Hz, 1H, CHali );
1.88–1.81 (m, 1H, CHali); 1.63–1.45 (m, 2H, CH2ali); 1.37–1.20
(m, 15H, CHali). 13C NMR (100 MHz, CDCl3): d = 214.7,
141.1, 131.6, 128.3, 121.8, 74.5, 58.8, 39.7, 27.3, 26.3, 25.9,
24.2, 23.7, 23.7, 22.68, 22.3, 21.5. FTIR (KBr) n = 3408.00,
3056.76, 2931.76, 2856.76, 1686.10, 1589.96, 1373.30, 1290.54,
1139.00, 1043.02, 821.01, 730.46, 599.60. HRMS (EI) m/z:
Calc. for C19H27BrO2; 366.1194 [M] +; Found 366.1194.
(E)-1-(2-Bromobenylidene) cyclododecanone (5b)
2-[(4-Ethylphenyl) (hydroxy) methyl] cyclododecanone (4j)
The crude residue was then purified by column chromato-
graphy on silica gel (n-hexane/EtOAc, 8 : 2) to afford the
monobenzylidene product 5b (2.624 g, 75%, E/Z = 98/2) as
a white crystalline solid; Mp: 111–113 1C; 1H NMR (400
MHz, CDCl3): d = 7.635–7.615 (m, 1H, CHAr); 7.288–7.256
(s, 1H, CHvinylic); 7.344–7.168 (m, 3H, CHAr); 2.877–2.846
(m, 2H, CH2ali); 2.539–2.509 (t, J = 12 Hz, 2H, CH2ali); 1.893
(bs, 2H, CH2ali); 1.318 (s, 11H, CH2ali); 1.241 (s, 1H, CHali);
1.132–1.107 (t, J = 10 Hz, 2H, CH2ali). 13C NMR (100 MHz,
CDCl3): d = 205.1, 142.8, 138.0, 136.5, 132.6, 130.5, 129.3,
127.1, 124.0, 38.8, 26.5, 26.5, 25.4, 24.4, 24.2, 24.1, 24.0, 23.1,
22.5. FTIR (KBr) n = 3483.16 [(broad peak) absence of OH
peak], 3064.86, 2938.19, 2860.89, 1661.57, 1464.88, 1358.90,
1239.37, 1113.73, 765.70, 742.36. HRMS (EI) m/z: Calc. for
C19H25BrO 348.1088 [M]+; Found 348.1089.
The crude residue was then purified by column chromato-
graphy on silica gel (n-hexane/EtOAc, 7 : 3) to afford the anti-
aldol product 4j (3.165 g, 85%, dr = 100) as a white crystalline
solid; Mp: 123–125 1C; 1H NMR (400 MHz, CDCl3): d =
7.262–7.242 (d, J = 8 Hz, 2H, CHAr); 7.196–7.176 (d, J = 8
Hz, 2H, CHAr); 4.800–4.771 (dd, J = 9.2, 6.4 Hz, 1H,
CH*(OH)); 2.983–2.928 (td,
J = 9.2, 3.6 Hz, 1H,
CH*–CHOH); 2.797–2.723 (qd, J = 9.2, 3.2 Hz, 1H, CHali);
2.753–2.619 (q, J = 15.2, 7.6 Hz, 2H, CH2ethylic); 2.531–2.458
(qd, J = 8.4, 3.2 Hz, 1H, CHali); 1.801–1.770 (ms, 1H, OH);
1.706–1.651 (m, 1H, CHali); 1.315–1.253 (m, 1H, CHali);
1.235–1.207 (t, J = 11.2 Hz, 3H, CH3ethylic); 1.199–1.182
(m, 16, CH2ali). 13C NMR (100 MHz, CDCl3): d = 214.9,
144.1, 139.4, 128.0, 126.6, 75.2, 59.3, 39.1, 28.5, 27.3, 26.4, 26.0,
24.2, 23.8, 23.7, 22.8, 22.3, 21.6, 15.5. FTIR (KBr) n = 3437.90,
3015.26, 2930.95, 2856.69, 1690.00, 1509.83, 1465.65, 1372.63,
1314.23, 1140.29, 1038.80, 831.36, 732.13. HRMS (EI) m/z:
Calc. for C21H32O2; 316.2402 [M]+; Found 316.2402.
(E)-1-(2,4-Dichlorobenylidene) cyclododecanone (5c)
The crude residue was then purified by column chromato-
graphy on silica gel (n-hexane/EtOAc, 8 : 2) to afford themono-
benzylidene product 5c (2.386 g, 70%, E/Z = 100) as a white
crystalline solid; Mp: 140–142 1C; 1H NMR (400 MHz,
CDCl3): d = 7.464–7.459 (d, J = 2 Hz, 1H, CHvinylic); 7.375
(s, 1H, CHAr); 7.284–7.258 (dd, 8, 2 Hz, 1H, CHAr);
7.231–7.210 (d, 8.4 Hz, 1H, CHAr ); 2.862–2.831 (m, 2H,
CH2ali); 2.517–2.831 (t, 12 Hz, 2H, CH2ali);1.859–1.852 (s, 2H,
2-[Hydroxy (napthalen-1-yl) methyl] cyclododecanone (4k)
The crude residue was then purified by column chromato-
graphy on silica gel (n-hexane/EtOAc, 7 : 3) to afford the anti-aldol
product 4k (3.165 g, 82%, dr = 100) as a white crystalline solid;
Mp: 131–133 1C; 1H NMR (400 MHz, CDCl3): d = 8.253–8.233
c
2300 New J. Chem., 2012, 36, 2292–2301
This journal is The Royal Society of Chemistry and the Centre National de la Recherche Scientifique 2012